Low‐dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients

Yin, Lu; Svigos, Katerina; Gutiérrez, Daniel; Peterson, Erik; Sicco, Kristen Lo; Shapiro, Jerry

doi:10.1111/jdv.17731

Cited by 7 publications

(7 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In both oral and topical forms, minoxidil has been shown to shorten hair follicle telogen phase, increase anagen phase duration, and increase hair diameter and length. 92 , 93 For example, one study by Yin et al showed that LDOM could result in an average addition of 9.4 hairs/cm 2 in patients after oral minoxidil alone was added to their treatment regimen, with LDOM ranging from 0.625 to 5 mg a day. 93 …”

Section: Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs

Alhanshali¹,

Buontempo²,

Sicco³

et al. 2023

CCID

View full text Add to dashboard Cite

Alopecia areata is an autoimmune hair loss disorder with variations in distribution, duration, and severity. The disease is chronic and often follows an unpredictable course, frequently leading to stress and anxiety for those who suffer from it. Throughout the years more knowledge has been gained regarding pathogenesis, diagnostic tools, impact on quality of life, as well as treatment strategies for alopecia areata. However, challenges in treating and alleviating the burden of disease remain. In this article, we discuss updates regarding the pathogenesis and treatment of alopecia areata and highlight unmet needs of the condition, including a review of limitations of current treatments, accessibility to management strategies, and the need for disease awareness and advocacy.

show abstract

Section: Treatmentmentioning

confidence: 99%

“… 92 , 93 For example, one study by Yin et al showed that LDOM could result in an average addition of 9.4 hairs/cm 2 in patients after oral minoxidil alone was added to their treatment regimen, with LDOM ranging from 0.625 to 5 mg a day. 93 …”

Section: Treatmentmentioning

confidence: 99%

Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs

Alhanshali¹,

Buontempo²,

Sicco³

et al. 2023

CCID

View full text Add to dashboard Cite

show abstract

“…These results are consistent with those published in studies assessing smaller cohorts of patients. 5 Both medications were well tolerated, with only two patients decreasing LDOM dosage during the study period, one due to light headedness and one due to facial hypertrichosis.…”

Section: Corp)mentioning

confidence: 88%

Comparing combination low‐dose oral minoxidil and topical minoxidil with oral minoxidil alone for the treatment of non‐scarring alopecia: A retrospective chart review

Klein

Karim

Shapiro

et al. 2022

J of Cosmetic Dermatology

View full text Add to dashboard Cite

“…When combined with other therapies, low dose can be used in the range of 0.5–2.5 mg; which ultimately yields lower side effects, that is, hypertrichosis and other vasodilatory effects such as peripheral fluid edema and postural hypotension. In a recent retrospective analysis in AGA patients, low dose oral minoxidil has found to increase both the hair density and hair thickness 9 …”

Section: Androgenetic Alopeciamentioning

confidence: 97%

“…In a recent retrospective analysis in AGA patients, low dose oral minoxidil has found to increase both the hair density and hair thickness. 9 Perera et al 17 effectively treated low dose oral minoxidil alone and with combination in chronic telogen effluvium. The average dose ranging from 0.5 to 2.5 mg of minoxidil was used in 36 patients for at least 6 months with marked improvement in hair density as well decreased hair shedding.…”

Section: Androg Ene Tic Alopeciamentioning

confidence: 99%

Comprehensive review of oral minoxidil in alopecia

Modha

Pathania

2022

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Background: There have been various treatment modalities available for alopecia in the form of topical and systemic with a variable response. The compliance of the patients is important in reaping results in alopecia. Minoxidil has come a long-way finding its use from topical formulations to systemic at lower dose in different alopecia.Objective: The objective of this article is to discuss various conditions in alopecia where oral minoxidil has found its role.Methods: A comprehensive literature search was performed relating to oral minoxidil role in various alopecia. Various clinical trials, case series, and case reports were searched on PubMed and Google Scholar. The references of available studies were also reviewed to collect the additional resources. Available data from various studies and case reports were collected and consolidated to provide a concise overview of oral minoxidil indications in various alopecia. Results:Oral minoxidil has been used in various non-scarring and scarring alopecia at a lower dosage with less side effects and with promising results. Androgenetic alopecia and female pattern hair loss were the two conditions where it has been used more commonly than other alopecia, providing a ray of hope along with overcoming the issues related to topical formulations and compliance.

show abstract

Low‐dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients

Cited by 7 publications

References 6 publications

Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs

Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs

Comparing combination low‐dose oral minoxidil and topical minoxidil with oral minoxidil alone for the treatment of non‐scarring alopecia: A retrospective chart review

Comprehensive review of oral minoxidil in alopecia

Contact Info

Product

Resources

About